Insider buying last 90 days
No open-market insider purchases were filed for CGNX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Cognex reported Q3 2026 results beating analyst estimates, with record quarterly revenue and continued margin expansion, prompting management to raise full-year adjusted EPS guidance to $1.68-$1.72 and sales guidance to $1.143 billion-$1.163 billion. Executives cited strong automation and logistics demand, cost discipline, and progress on AI-powered machine vision, including a planned acquisition of RealSense expected to close in the fourth quarter. Despite the beat and raised outlook, a separate report on the same day noted that although revenue of $313 million and EPS of $0.50 met expectations, analysts trimmed their consensus price target by 8.5% to $72.63.
CGNX closed at $50.34, up 5.4% on the day, though the stock remains well below both its 50-day average of $58.85 and 200-day average of $58.24, reflecting a mixed trend after declines of 20% over one month and three months and 25.2% over six months, against a 27.3% one-year gain. The GekkoIndex reads 70.4, placing the stock in the Buying zone. Price sits 10.7% below Gekko Fair Value of $56.40.
The next earnings date is 10 February 2027, 87 days away, outside a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality over the next 20 trading days has averaged -2.6% across 5 years, with gains in 2 of those years, a factor worth noting alongside the current gap to fair value.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Cognex scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
Below 50 and 200-day
Close $50.01 is below the 50-day ($58.08) and 200-day ($58.47) averages, and the 50-day is below the 200-day.
See the chart65.9, Accumulation
Reading 65.9 is in the Accumulation zone.
See the GekkoIndex7.1% below
Price is 7.1% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 87 days
Next report Feb 10, 2027, 87 days away — outside a typical 20-trading-day hold.
See earnings−3.4% on average
From this point in the calendar, the next 20 trading days averaged −3.4% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Cognex closed at $50.01 on Nov 13, 2026, +31.0% over the past year, inside a 52-week range of $34.60 to $72.88.
Use the left and right arrow keys to read daily values.
Put CGNX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Cognex builds machine vision technology that allows factories and warehouses to automate the way they manufacture, inspect and track products. Its systems interpret visual data to locate, identify, measure and check items as they move from production through to delivery, and its customers include makers of mobile devices, pharmaceutical packaging and automotive components. The company is recognized for this kind of image-based automation used across manufacturing and logistics settings.
Its product range spans software tools such as VisionPro and QuickBuild for building vision applications, along with deep learning vision software, vision sensors, the In-Sight line of integrated vision systems, and the DataMan barcode reading and verification products. These tools handle tasks like confirming part presence, measuring dimensions, checking assembly accuracy and guiding robotic equipment. Cognex reaches customers in consumer electronics, automotive, consumer goods, food and beverage, pharmaceuticals and medical device production, selling both directly and through a network of partners and system integrators worldwide.
Cognex was founded in 1981 and is headquartered in Natick, Massachusetts. Its shares are listed on the NASDAQ under the ticker CGNX.
Cognex’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65.9, in the Accumulation zone, down 9 points over five sessions.
Down 9 points over five sessions, from the Buying zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 42 | +0.6% | +5.1% | ||
| Accumulation (current zone) | 203 | +1.2% | +2.2% | ||
| Neutral | 407 | +0.2% | +2.4% | ||
| Distribution | 44 | −0.4% | −3.6% | ||
| Selling | 6 | Too few readings yet | |||
Average CGNX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Cognex trades 7.1% below Gekko Fair Value of $53.81, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Cognex shares are worth, recalculated every trading day.
$53.81
Gekko Fair Value, Nov 13, 2026
7.1% Undervalued
At the end of Aug 2026 the price was 21.7% above the estimate.
No open-market insider purchases were filed for Cognex, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for CGNX in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in CGNX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Cognex has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold CGNX.
Cognex reports on Feb 10, 2027, before the open (87 days away), and beat the EPS estimate in 8 of its last 8 reports.
Feb 10, 2027
Expected before the open, 87 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $0.45 est $0.42 | $291.3M est $292.1M | −5.8% |
| May 6, 2026 | $0.34 est $0.25 | $268.4M est $246.0M | +12.1% |
| Feb 11, 2026 | $0.27 est $0.22 | $252.3M est $239.0M | +34.6% |
| Oct 29, 2025 | $0.33 est $0.27 | $276.9M est $238.9M | −12.6% |
| Jul 30, 2025 | $0.25 est $0.23 | $249.1M est $248.2M | +19.0% |
| Apr 30, 2025 | $0.16 est $0.13 | $216.0M est $248.8M | +3.8% |
| Feb 12, 2025 | $0.20 est $0.15 | $229.7M est $220.7M | −14.4% |
| Oct 30, 2024 | $0.20 est $0.19 | $234.7M est $220.9M | −0.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Cognex is $71.42, +42.8% from the last close, from 13 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 13 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | Jefferies | $64 | +28.0% |
| Nov 9 | D.A. Davidson | $55 | +10.0% |
| Nov 8 | Goldman Sachs | $87 | +74.0% |
| Nov 6 | Truist Financial | $57 | +14.0% |
| Nov 6 | Stephens | $70 | +40.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Cognex averaged −3.4% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −3.2% | 2 of 5 |
| Next 10 trading days | −2.1% | 2 of 5 |
| Next 15 trading days | −2.2% | 2 of 5 |
| Next 20 trading days | −3.4% | 2 of 5 |
| Next 30 trading days | −2.6% | 1 of 5 |
For scale, CGNX’s typical 20-trading-day move in either direction is about 7.4%.
Cognex’s market cap is $8.42B, with a P/E ratio of 36.2 and revenue of $1.13B over the last twelve months.
Coverage of Cognex this week reads neutral: 0 positive, 3 neutral and 1 negative headlines.
Cognex’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| EMREmerson Electric | Neutral | 16.5% above |
| KEYSKeysight Technologies | Accumulation | 3.4% below |
| QQnity Electronics | Neutral | 4.7% below |
| FTVFortive | Neutral | 15.1% above |
| NXTNextpower | Neutral | 3.0% below |
| NVMINova | Neutral | 4.2% above |
A peer links to its own page where one exists.
Cognex’s market cap is $8.42B at the Nov 13, 2026 close of $50.01, with 168.4M shares outstanding. The shares trade on a P/E ratio of 36.2.
The consensus analyst 12-month price target for Cognex is $71.42, +42.8% from the last close. Of the 13 firms that rated the stock in the last 90 days, 9 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Cognex is undervalued: the Nov 13, 2026 close of $50.01 is 7.1% below Gekko Fair Value of $53.81. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Cognex is expected to report on Feb 10, 2027, before the market opens (87 days away). Analysts expect earnings of $0.40 per share on revenue of $281.1M. Cognex beat the earnings estimate in 8 of its last 8 reports, moving 12.9% on average across the report.
Cognex’s 52-week high is $72.88 and its 52-week low is $34.60; it closed at $50.01 on Nov 13, 2026, +31.0% over the past year. Over the last five years the shares peaked at $84.00 on Nov 16, 2021.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.